LUPI is an indipendent Business Unit of H. Lundbeck A/S, global pharmaceutical company engaged in research and development, production, marketing and sales of drugs for the treatment of psychiatric and neurological disorders.

Founded in 1915 by Hans Lundbeck and listed on the NASDAQ OMX Copenhagen Stock Exchange in 1999, today Lundbeck is a global highly committed pharmaceutical company engaged in development of pharmaceuticals for the treatment of brain diseases on the basis of in-house research, and has grown to a company that employs more then 6000 employees worldwide.

With a long tradition of advanced corporate responsibility and ethical behaviour, Lundbeck's mission is to improve the quality of life for people suffering from psychiatric and neurological disorders.

Hans and Grete Lundbeck
You are about to leave Lundbeck Pharmaceuticals Italy homepage